SHR-1703

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SHR-1703, covering 2025-05-28 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients [Phase 2]

See pricing